{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:54:18Z","timestamp":1771473258518,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12328-024-02074-y","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T07:29:11Z","timestamp":1734938951000},"page":"137-144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Successful portosystemic shunt embolization resolves hepatic encephalopathy and enhances hepatic function and glycemic control in MASH-related cirrhosis: a case report"],"prefix":"10.1007","volume":"18","author":[{"given":"Yoshiaki","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0430-6819","authenticated-orcid":false,"given":"Takanobu","family":"Iwadare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takefumi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kurozumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayoi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeji","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"2074_CR1","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/hep.28906","volume":"65","author":"G Garcia-Tsao","year":"2017","unstructured":"Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65:310\u201335.","journal-title":"Hepatology"},{"key":"2074_CR2","doi-asserted-by":"publisher","first-page":"14848","DOI":"10.1038\/s41598-024-65690-1","volume":"14","author":"Q Ke","year":"2024","unstructured":"Ke Q, He J, Cai L, et al. Safety and efficacy of interventional embolization in cirrhotic patients with refractory hepatic encephalopathy associated with spontaneous portosystemic shunts. Sci Rep. 2024;14:14848.","journal-title":"Sci Rep"},{"key":"2074_CR3","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3748\/wjg.v26.i15.1726","volume":"26","author":"S Nardelli","year":"2020","unstructured":"Nardelli S, Riggio O, Gioia S, et al. Spontaneous porto-systemic shunts in liver cirrhosis: clinical and therapeutical aspects. World J Gastroenterol. 2020;26:1726.","journal-title":"World J Gastroenterol"},{"key":"2074_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.4254\/wjh.v12.i9.533","volume":"12","author":"W Chung","year":"2020","unstructured":"Chung W, Promrat K, Wands J. Clinical implications, diagnosis, and management of diabetes in patients with chronic liver diseases. World J Hepatol. 2020;12:533.","journal-title":"World J Hepatol"},{"key":"2074_CR5","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/liv.13115","volume":"36","author":"L Elkrief","year":"2016","unstructured":"Elkrief L, Rautou PE, Sarin S, et al. Diabetes mellitus in patients with cirrhosis: clinical implications and management. Liver Int. 2016;36:936\u201348.","journal-title":"Liver Int"},{"key":"2074_CR6","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s00535-024-02100-3","volume":"59","author":"H Uojima","year":"2024","unstructured":"Uojima H, Yamasaki K, Sugiyama M, et al. Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation. J Gastroenterol. 2024;59:598\u2013608. https:\/\/doi.org\/10.1007\/s00535-024-02100-3.","journal-title":"J Gastroenterol"},{"key":"2074_CR7","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3748\/wjg.v24.i11.1239","volume":"24","author":"N Fujimori","year":"2018","unstructured":"Fujimori N, Umemura T, Kimura T, et al. Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease. World J Gastroenterol. 2018;24:1239.","journal-title":"World J Gastroenterol"},{"key":"2074_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s43856-024-00499-7","volume":"4","author":"T Iwadare","year":"2024","unstructured":"Iwadare T, Kimura T, Okumura T, et al. Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease. Commun Med. 2024;4:73.","journal-title":"Commun Med"},{"key":"2074_CR9","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1053\/j.gastro.2018.01.028","volume":"154","author":"M Sim\u00f3n-Talero","year":"2018","unstructured":"Sim\u00f3n-Talero M, Roccarina D, Mart\u00ednez J, et al. Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis. Gastroenterology. 2018;154:1694\u2013705.","journal-title":"Gastroenterology"},{"key":"2074_CR10","first-page":"142","volume":"5","author":"S Elwir","year":"2017","unstructured":"Elwir S, Rahimi RS. Hepatic encephalopathy: an update on the pathophysiology and therapeutic options. J Clin Transl Hepatol. 2017;5:142.","journal-title":"J Clin Transl Hepatol"},{"key":"2074_CR11","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.cgh.2022.04.034","volume":"20","author":"MA Fallahzadeh","year":"2022","unstructured":"Fallahzadeh MA, Rahimi RS. Hepatic encephalopathy: current and emerging treatment modalities. Clin Gastroenterol Hepatol. 2022;20:S9\u201319.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2074_CR12","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1046\/j.1440-1746.2000.02283.x","volume":"15","author":"A Watanabe","year":"2000","unstructured":"Watanabe A. Portal-systemic encephalopathy in non-cirrhotic patients: classification of clinical types, diagnosis and treatment. J Gastroenterol Hepatol. 2000;15:969\u201379.","journal-title":"J Gastroenterol Hepatol"},{"key":"2074_CR13","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.jceh.2018.04.008","volume":"8","author":"S Nardelli","year":"2018","unstructured":"Nardelli S, Gioia S, Ridola L, et al. Radiological intervention for shunt related encephalopathy. J Clin Exp Hepatol. 2018;8:452\u20139.","journal-title":"J Clin Exp Hepatol"},{"key":"2074_CR14","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1002\/hep.26314","volume":"57","author":"W Laleman","year":"2013","unstructured":"Laleman W, Simon-Talero M, Maleux G, et al. Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology. 2013;57:2448\u201357.","journal-title":"Hepatology"},{"key":"2074_CR15","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/lt.24440","volume":"22","author":"AM Lynn","year":"2016","unstructured":"Lynn AM, Singh S, Congly SE, et al. Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy. Liver Transpl. 2016;22:723\u201331.","journal-title":"Liver Transpl"},{"key":"2074_CR16","doi-asserted-by":"publisher","DOI":"10.2147\/HMER.S169024","author":"CA Philips","year":"2019","unstructured":"Philips CA, Rajesh S, Augustine P, et al. Portosystemic shunts and refractory hepatic encephalopathy: patient selection and current options. Hepatic Med Evid Res. 2019. https:\/\/doi.org\/10.2147\/HMER.S169024.","journal-title":"Hepatic Med Evid Res."},{"key":"2074_CR17","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1111\/apt.12771","volume":"39","author":"J An","year":"2014","unstructured":"An J, Kim K, Han S, et al. Improvement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy. Aliment Pharmacol Ther. 2014;39:1418\u201326.","journal-title":"Aliment Pharmacol Ther"},{"key":"2074_CR18","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1111\/jgh.16280","volume":"38","author":"WM Choi","year":"2023","unstructured":"Choi WM, Yoo SY, Chang JI, et al. A model for predicting poor survival in patients with cirrhosis undergoing portosystemic shunt embolization. J Gastroenterol Hepatol. 2023;38:1629\u201336.","journal-title":"J Gastroenterol Hepatol"},{"key":"2074_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12072-022-10418-4","volume":"17","author":"A Mukund","year":"2023","unstructured":"Mukund A, Choudhury SP, Tripathy TP, et al. Influence of shunt occlusion on liver volume and functions in hyperammonemic cirrhosis patients having large porto-systemic shunts: a randomized control trial. Hep Intl. 2023;17:150\u20138. https:\/\/doi.org\/10.1007\/s12072-022-10418-4.","journal-title":"Hep Intl"},{"key":"2074_CR20","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00535-013-0893-z","volume":"49","author":"T Ishikawa","year":"2014","unstructured":"Ishikawa T, Shiratsuki S, Matsuda T, et al. Occlusion of portosystemic shunts improves hyperinsulinemia due to insulin resistance in cirrhotic patients with portal hypertension. J Gastroenterol. 2014;49:1333\u201341.","journal-title":"J Gastroenterol"},{"key":"2074_CR21","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/S0735-1097(01)01129-9","volume":"37","author":"KJ Mather","year":"2001","unstructured":"Mather KJ, Verma S, Anderson TJ. Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol. 2001;37:1344\u201350.","journal-title":"J Am Coll Cardiol"},{"key":"2074_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4093\/dmj.2023.0128","volume":"48","author":"Y-H Park","year":"2024","unstructured":"Park Y-H, Sohn M, Lee SY, et al. Two-year therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and empagliflozin in drug-na\u00efve type 2 diabetes mellitus patients. Diabetes Metab J. 2024;48:253\u201364.","journal-title":"Diabetes Metab J"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02074-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-024-02074-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02074-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:17:04Z","timestamp":1738329424000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-024-02074-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2074"],"URL":"https:\/\/doi.org\/10.1007\/s12328-024-02074-y","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"3 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report and accompanying images. A copy of the written consent form is available for review by the Editor-in-Chief of this journal upon request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}